Health Sciences, University of York, York, UK.
Social Policy, University of Birmingham, Birmingham, UK.
Curr Psychiatry Rep. 2019 Jun 4;21(7):48. doi: 10.1007/s11920-019-1044-x.
This paper provides an update from the literature on understanding of the relationship between cannabis and schizophrenia. In particular, the paper focuses on the latest findings and remaining areas that require investigation.
Three hypotheses have emerged as potential explanations for the association between cannabis and schizophrenia, namely cannabis can trigger schizophrenia, cannabis is used to mitigate symptoms of schizophrenia, and there are common factors which might account for the association. Biological and genetic factors dominate this field of research; this has been at the expense of exploring social and cultural contributory factors which influence cannabis and schizophrenia. The evidence for cannabis acting as a causal factor for schizophrenia has so far not been established. Research needs to extend beyond males drawn from western countries if we are to advance knowledge and understanding of the link between cannabis use and schizophrenia.
本文从文献角度提供了对大麻和精神分裂症之间关系的理解的最新更新。特别是,本文重点介绍了最新的发现和仍需要研究的领域。
有三个假设已经出现,作为大麻和精神分裂症之间关联的潜在解释,即大麻可能引发精神分裂症,大麻用于缓解精神分裂症的症状,以及可能存在共同因素可以解释这种关联。生物和遗传因素主导了这一研究领域;这是以牺牲探索影响大麻和精神分裂症的社会和文化促成因素为代价的。大麻作为精神分裂症的因果因素的证据尚未得到确立。如果我们要推进对大麻使用和精神分裂症之间联系的认识和理解,就需要将研究对象扩大到来自西方国家的男性以外的人群。